Circulating osteopontin per tumor volume as a prognostic biomarker for resectable intrahepatic cholangiocarcinoma
Kaiqian Zhou(Ministry of Education), Zheng Wang(McMaster University), Yuan‐Fei Peng(Fudan University), Cheng Zhou(Fudan University), Jie Hu(Zhongshan Hospital), Jian Zhou(Shenzhen University Health Science Center), Yun‐Fan Sun(Zhongshan Hospital), Feiyu Chen(Sun Yat-sen University), Jia Fan(Nanjing Tech University), Liu‐Xiao Yang(Sun Yat-sen University), Xiangyu Zhang(North China Electric Power University), Lei Yu(Taiyuan Central Hospital)
Cited by 23
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644